National public health institutes

InvestChile Promotes Pharmaceutical Companies Landing in South America's Business Hub

Retrieved on: 
Wednesday, April 20, 2022

It was in response to this scenario that InvestChile, Chile's Foreign Investment Promotion Agency, together with the Public Health Institute (ISP), launched its new e-book "The pharmaceutical industry in Chile: Installed capacity, stakeholders, investment incentives" .

Key Points: 
  • It was in response to this scenario that InvestChile, Chile's Foreign Investment Promotion Agency, together with the Public Health Institute (ISP), launched its new e-book "The pharmaceutical industry in Chile: Installed capacity, stakeholders, investment incentives" .
  • The e-book compiles information and provides details on the health authorities, the permits needed for medical establishments and studies, sanitary registration and regulations, and the benefits that foreign companies can access when investing in the sector in Chile.
  • The document reveals that Chile's pharmaceutical industry moves around US $1.8 billion, equivalent to 0.73% of national GDP, and has a positive impact on other sectors of the economy, such as manufacturing, commerce, and transportation.
  • Among the benefits that Chile represents for foreign pharmaceutical companies in search of an investment destination is the wide network of free trade agreements signed by the country, which favor exports and make it possible for companies to respond to the demand for pharmaceutical products in the region and around the world.

Genetic Technologies Reports Q2 FY22 Cash Flow Results

Retrieved on: 
Wednesday, January 19, 2022

Emergence of new strains of COVID-19, such as Omicron, highlight the importance and utility of GENEs COVID-19 Risk Test.

Key Points: 
  • Emergence of new strains of COVID-19, such as Omicron, highlight the importance and utility of GENEs COVID-19 Risk Test.
  • As part of the EasyDNA integration, the Company announced the launch of the geneType rebrand in November 2021.
  • Total cash receipts for the quarter from EasyDNA were A$1.8 million in line with acquisition expectations.
  • The Company will provide an investor webinar to discuss the quarterly results.

Genetic Technologies Reports Q1 FY22 Results

Retrieved on: 
Monday, October 25, 2021

The Multi-Test is a Predictive Panel Risk Test to cover six common cancers which account for ~70% of annual morbidities.

Key Points: 
  • The Multi-Test is a Predictive Panel Risk Test to cover six common cancers which account for ~70% of annual morbidities.
  • Phase one launch to include Breast Cancer, Colorectal Cancer, Prostate Cancer, Ovarian Cancer, Coronary Artery Disease and Type-2 Diabetes.
  • Commenting on the quarter, CEO Simon Morriss stated: This past quarter demonstrates the forward trajectory and momentum Genetic Technologies has established.
  • Authorised for release by the Board of Genetic Technologies Limited.

GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity

Retrieved on: 
Tuesday, September 28, 2021

The purpose of the study is to incorporate further research and data on women of African descent to provide expanded testing capabilities for the GeneType for Breast Cancer product.

Key Points: 
  • The purpose of the study is to incorporate further research and data on women of African descent to provide expanded testing capabilities for the GeneType for Breast Cancer product.
  • There exists a significant unmet need for polygenic risk testing for ethnically diverse populations where risks of mortality from Breast Cancer is estimated to be 40% higher in African American women than Caucasian women1.
  • Professor Colditz is a world-renowned figure in breast cancer epidemiology and risk modelling, with notable genotype datasets on the African American population held by the Institute for Public Health.
  • The lifetime probability of developing non-hereditary breast cancer is 11.5% (1 in 9) for the African American population in the USA1.

COVID-19 Pulmonary, ARDS and Ventilator Resources Now Available in Spanish

Retrieved on: 
Tuesday, September 14, 2021

ALISO VIEJO, Calif., Sept. 14, 2021 /PRNewswire/ -- A joint effort between the American Association of Critical-Care Nurses ( AACN ) and projects funded by the United States Agency for International Development (USAID) has made AACN's free " COVID-19 Pulmonary, ARDS and Ventilator Resources " online course available in Spanish.

Key Points: 
  • ALISO VIEJO, Calif., Sept. 14, 2021 /PRNewswire/ -- A joint effort between the American Association of Critical-Care Nurses ( AACN ) and projects funded by the United States Agency for International Development (USAID) has made AACN's free " COVID-19 Pulmonary, ARDS and Ventilator Resources " online course available in Spanish.
  • Throughout the 4.5-hour course, learners are immersed in real-world intensive care unit scenarios, while interactive elements encourage the development of safe and effective practices.
  • The Spanish-language version of "COVID-19 Pulmonary, ARDS and Ventilator Resources" is available on the Open Critical Care Learning Management System site.
  • "COVID-19 Pulmonary, ARDS and Ventilator Resources" was initially developed by teams of experts at AACN.

Africa CDC and Ginkgo Bioworks Announce Collaboration to Strengthen Laboratory Network Capacity Across African Union Member States

Retrieved on: 
Tuesday, September 14, 2021

BOSTON and ADDIS ABABA, Ethiopia, Sept. 14, 2021 /PRNewswire/ -- The Africa Centres for Disease Control and Prevention (Africa CDC), a specialized technical institution of the African Union, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to bolster the laboratory network capacity for African Union Member States.

Key Points: 
  • BOSTON and ADDIS ABABA, Ethiopia, Sept. 14, 2021 /PRNewswire/ --The Africa Centres for Disease Control and Prevention (Africa CDC), a specialized technical institution of the African Union, and Ginkgo Bioworks, which is building the leading horizontal platform for cell programming, today announced a partnership to bolster the laboratory network capacity for African Union Member States.
  • In consultation with Africa CDC, Ginkgo Bioworks will assess existing automation, data analysis and bioinformatics capabilities across the continent.
  • This information will be used to expand throughput throughout the continental network and inform African Union Member States' investments in automation and additional lab capacity.
  • The African Unionis a continental bodythat leads Africa's development and integration in close collaboration with the 55 Member States, the Regional Economic Communities and African citizens.